Literature DB >> 8576279

Different expression patterns of cyclins A, D1 and E in human colorectal cancer.

A Wang1, N Yoshimi, M Suzui, A Yamauchi, M Tarao, H Mori.   

Abstract

The expressions of cyclins A, D1 and E at the protein level were investigated by Western blotting in human colorectal carcinomas and in adjacent non-neoplastic colorectal mucosas. Cyclin E was higher in the cancer tissue than in the non-neoplastic mucosa in 92% patients (35 out of 38 cases). However, the cyclin A expression of the mucosa was higher than that of the cancer tissue in 63% (25 out of 40 cases) cases, and only 4 (10%) cancers had higher cyclin A expression. Eleven cancers (27%) demonstrated expression equivalent to that in the mucosa. Equal expression of cyclin D1 in cancer and mucosal tissues was found in 51% cases (20/39), lower expression of cyclin D1 by cancer tissues was demonstrated in 41% cases (16/39) and only three cancers showed higher expression than the mucosa. Proliferating-cell nuclear antigen immunohistochemistry revealed that the labeling index of the cancer tissue was 43.5 +/- 8.3% while that of the mucosa was only 14.8 +/- 5.1%. These results proved that colorectal cancers express high levels of cyclin E, consistent with a high rate of cell proliferation, whereas most of such cancer lose control of cyclin A and cyclin D1 expression.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8576279     DOI: 10.1007/bf01226270

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  26 in total

1.  Cyclin A is required in S phase in normal epithelial cells.

Authors:  F Zindy; E Lamas; X Chenivesse; J Sobczak; J Wang; D Fesquet; B Henglein; C Bréchot
Journal:  Biochem Biophys Res Commun       Date:  1992-02-14       Impact factor: 3.575

2.  Cyclin E and cyclin A as candidates for the restriction point protein.

Authors:  Q P Dou; A H Levin; S Zhao; A B Pardee
Journal:  Cancer Res       Date:  1993-04-01       Impact factor: 12.701

3.  Amplification of cyclin genes in colorectal carcinomas.

Authors:  F S Leach; S J Elledge; C J Sherr; J K Willson; S Markowitz; K W Kinzler; B Vogelstein
Journal:  Cancer Res       Date:  1993-05-01       Impact factor: 12.701

4.  Protein kinase C-mediated inhibition of cyclin A expression in human vascular endothelial cells.

Authors:  C Kosaka; T Sasaguri; J Masuda; K Zen; K Shimokado; T Yokota; J Ogata
Journal:  Biochem Biophys Res Commun       Date:  1993-06-30       Impact factor: 3.575

5.  Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts.

Authors:  D E Quelle; R A Ashmun; S A Shurtleff; J Y Kato; D Bar-Sagi; M F Roussel; C J Sherr
Journal:  Genes Dev       Date:  1993-08       Impact factor: 11.361

6.  Redundant cyclin overexpression and gene amplification in breast cancer cells.

Authors:  K Keyomarsi; A B Pardee
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205

7.  The PRAD-1/cyclin D1 oncogene product accumulates aberrantly in a subset of colorectal carcinomas.

Authors:  J Bartkova; J Lukas; M Strauss; J Bartek
Journal:  Int J Cancer       Date:  1994-08-15       Impact factor: 7.396

8.  The inhibitory effect of magnesium hydroxide on the bile acid-induced cell proliferation of colon epithelium in rats with comparison to the action of calcium lactate.

Authors:  A Wang; N Yoshimi; T Tanaka; H Mori
Journal:  Carcinogenesis       Date:  1994-11       Impact factor: 4.944

9.  Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family.

Authors:  A Koff; F Cross; A Fisher; J Schumacher; K Leguellec; M Philippe; J M Roberts
Journal:  Cell       Date:  1991-09-20       Impact factor: 41.582

10.  Cyclin A is required at two points in the human cell cycle.

Authors:  M Pagano; R Pepperkok; F Verde; W Ansorge; G Draetta
Journal:  EMBO J       Date:  1992-03       Impact factor: 11.598

View more
  14 in total

1.  Novel splice variants of cyclin E with altered substrate specificity.

Authors:  D C Porter; K Keyomarsi
Journal:  Nucleic Acids Res       Date:  2000-12-01       Impact factor: 16.971

2.  Cyclin E and chromosome instability in colorectal cancer cell lines.

Authors:  C Simone; N Resta; L Bagella; A Giordano; G Guanti
Journal:  Mol Pathol       Date:  2002-06

3.  Overexpression of cyclin B1 in human colorectal cancers.

Authors:  A Wang; N Yoshimi; N Ino; T Tanaka; H Mori
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

Review 4.  Development and progression of colorectal neoplasia.

Authors:  Upender Manne; Chandrakumar Shanmugam; Venkat R Katkoori; Harvey L Bumpers; William E Grizzle
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

5.  Expression of cyclins and cyclin dependent kinases in human benign and malignant melanocytic lesions.

Authors:  J Georgieva; P Sinha; D Schadendorf
Journal:  J Clin Pathol       Date:  2001-03       Impact factor: 3.411

6.  Circadian variation in expression of G1 phase cyclins D1 and E and cyclin-dependent kinase inhibitors p16 and p21 in human bowel mucosa.

Authors:  John Griniatsos; Othon P Michail; Stamatios Theocharis; Antonios Arvelakis; Ioannis Papaconstantinou; Evangelos Felekouras; Emmanouel Pikoulis; Ioannis Karavokyros; Chris Bakoyiannis; George Marinos; John Bramis; Panayiotis O Michail
Journal:  World J Gastroenterol       Date:  2006-04-07       Impact factor: 5.742

Review 7.  Cyclins and cyclin-dependent kinases: from biology to tumorigenesis and therapeutic opportunities.

Authors:  Mitra Zabihi; Ramin Lotfi; Amir-Mohammad Yousefi; Davood Bashash
Journal:  J Cancer Res Clin Oncol       Date:  2022-07-04       Impact factor: 4.553

8.  Expression of cyclin E in stage III colorectal carcinoma.

Authors:  Lea Rath-Wolfson; Michael Bergman; Yaacov Ori; Alex Goldman; Edward Ram; Rumelia Koren; Hertzel Salman
Journal:  Oncol Lett       Date:  2012-10-05       Impact factor: 2.967

9.  Immunohistochemical expression of cyclin D1, cyclin E, p21/waf1 and p27/kip1 in inflammatory bowel disease: correlation with other cell-cycle-related proteins (Rb, p53, ki-67 and PCNA) and clinicopathological features.

Authors:  Elli E Ioachim; Konstantinos H Katsanos; Michael C Michael; Epameinondas V Tsianos; Niki J Agnantis
Journal:  Int J Colorectal Dis       Date:  2004-04-02       Impact factor: 2.571

Review 10.  Targeting cyclin-dependent kinases in human cancers: from small molecules to Peptide inhibitors.

Authors:  Marion Peyressatre; Camille Prével; Morgan Pellerano; May C Morris
Journal:  Cancers (Basel)       Date:  2015-01-23       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.